Establishing cost-effectiveness of atypical neuroleptics

British Journal of Psychiatry

Volumn 171, Issue AUG., 1997, Pages 103-104

  Robert, G ^a   Kennedy, P ^a  

^a York Health Services NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

COST EFFECTIVENESS ANALYSIS; DRUG COST; EDITORIAL; HUMAN; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 0030796663     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.171.2.103     Document Type: Editorial

References (5)